Jazz Pharmaceuticals plc — Director's Dealing 2015

Aug 11, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2015-08-07

Reporting Person: Cox Russell J. (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-08-07	Ordinary Shares	F	978	$181.79	Disposed	63667	Direct
2015-08-10	Ordinary Shares	F	4565	$181.48	Disposed	59102	Direct

Footnotes

F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

F2: Includes 92 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 29, 2015.